» Articles » PMID: 2458944

CD4+CD45R+ Cells Are Preferentially Activated Through the CD2 Pathway

Overview
Journal Eur J Immunol
Date 1988 Sep 1
PMID 2458944
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

CD4 cell subsets, CD4+CD45R+ (CDw29-) cells and CD4+CD45R- (CDw29+) cells, can be differently triggered by various stimuli and possess distinct functions. In the present study, cell activation in CD4+CD45R+ and CD4+CD45R- subsets mediated by CD3-Ti antigen-receptor complex or CD2 molecule were examined by using anti-CD3 antibody or pairs of anti-CD2 antibodies (anti-T11(2) and anti-T11(3) antibodies). The results showed that CD4+CD45R+ cells were preferentially activated through the CD2 pathway, whereas both subsets were equally activated through the CD3-Ti antigen-receptor pathway when a second signal such as monocytes or interleukin 2 was present. The different responsiveness of CD4+CD45R+ and CD4+CD45R- subsets through the CD2 molecule did not appear to be due to differences in the distribution or number of T11(2) and T11(3) determinants. These data suggest that some part of the functional diversity of CD4 cell subsets might be explained by the differences in cell activation through the CD2 molecule.

Citing Articles

CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells.

Reinhold U, Liu L, Sesterhenn J, Abken H Immunology. 1996; 89(3):391-6.

PMID: 8958052 PMC: 1456566. DOI: 10.1046/j.1365-2567.1996.d01-744.x.


CD2-mediated stimulation of the naive CD4+ T-cell subset promotes the development of skin-associated cutaneous lymphocyte antigen-positive memory cells.

Liu L, Foer A, Sesterhenn J, Reinhold U Immunology. 1996; 88(2):207-13.

PMID: 8690452 PMC: 1456419. DOI: 10.1111/j.1365-2567.1996.tb00006.x.


Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.

Nijhuis E, Remarque E, Hinloopen B, van der Pouw-Kraan T, van Lier R, Ligthart G Clin Exp Immunol. 1994; 96(3):528-34.

PMID: 7911751 PMC: 1534577. DOI: 10.1111/j.1365-2249.1994.tb06061.x.


Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Zielen S, Dengler T, Bauscher P, Meuer S Clin Exp Immunol. 1994; 96(2):253-9.

PMID: 7910535 PMC: 1534907. DOI: 10.1111/j.1365-2249.1994.tb06550.x.


Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

Matsuyama T, Yamada A, Kay J, Yamada K, Akiyama S, Schlossman S J Exp Med. 1989; 170(4):1133-48.

PMID: 2477485 PMC: 2189458. DOI: 10.1084/jem.170.4.1133.